| Ytd | -70.48% | |
| 1y | -50.06% |
| Open | 4.17 | Prev Close | 4.26 | Low | 4.11 | High | 4.20 | Mkt Cap | 8.55M |
| Vol | 899.00 | Avg Vol | 243.94K | EPS | -29.56 | P/E | -0.14 | Forward P/E | -0.43 |
| Beta | 1.52 | Short Ratio | 0.20 | Inst. Own | 5.89% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 4.74 | 200-d Avg | 9.07 | 1yr Est | 4.50 |
QNRX News
Quoin Expects to Initiate Phase 2 Study in 2H 2026, Study Plans to Enroll 6-8 Pediatric and Adult Pa
Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) ("Quoin" or the "Company"), a late clinica
Gainers Pulsenmore (NASDAQ:PLSM) stock increased by 152.0% to $8.59 during Wednesday's pre-mark
Leifras Co Ltd (NASDAQ: LFS) rose in pre-market trading after acquiring SWIFT JAPAN for JPY454.6 mil
Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 40.3% to $4.56 during Tuesday's after-m
Quoin Pharmaceuticals Ltd. (NASDAQ:QNRX) ("Quoin" or the "Company"), a late clinical
The formation follows the recent grant of Orphan Drug Designation to QRX003 by Japan's Ministry
Six pediatric NS patients are currently enrolled in the program, all under 10 years of age, with the
Quoin Pharmaceuticals Ltd. (NASDAQ:QNRX) ("Quoin" or the "Company"), a late clinical
The IND submission is supported by clinical observations from Quoin's ongoing investigator-led p
Quoin Pharmaceuticals (NASDAQ:QNRX) reported quarterly losses of $(1.77) per share which missed the
LUCID CAPITAL MARKETS analyst Dev Prasad initiates coverage on Quoin Pharmaceuticals (NASDAQ:QNR
Quoin Pharmaceuticals (NASDAQ:QNRX) reported quarterly losses of $(1.74) per share which beat the an
FDA indicated that a single Phase 3 study may be sufficient to support marketing approval in the U.S
Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) ("Quoin" or the "Company"), a late clinica
Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company
During Thursday's session, 406 companies made new 52-week lows.
Wednesday's session saw 269 companies set new 52-week lows.
During Monday's trading, 1214 companies set new 52-week lows.
During Thursday, 849 stocks hit new 52-week lows.